Literature DB >> 27989346

Assessment of Multipotent Mesenchymal Stromal Cells in Bone Marrow Aspirate From Human Calcaneus.

Chunmei Li1, Cory D Kilpatrick2, Shannon Smith1, Dean L Glettig1, Douglas J Glod2, Jason Mallette2, Michael R Strunk3, Jerry Chang3, Siddhesh R Angle3, David L Kaplan1.   

Abstract

Bone marrow aspirates (BMAs), owing to their innate osteogenic potential, are well-documented supplements to osteoconductive and/or osteoinductive materials. The calcaneal body provides foot and ankle surgeons a convenient harvest site with low morbidity and minimal cost. In the present study, we sought to identify and characterize multipotent mesenchymal stromal cells (MSCs) in BMAs harvested from the human calcaneal body. Ten healthy patients aged 18 to 65 years were enrolled in the present study. BMAs were harvested from the patients without any reported postoperative complications related to the harvest. Cells isolated from all the aspirates were adherent to culture plates and expressed positive MSC surface markers (CD105, CD90, and CD73) and a low level of negative MSC markers (CD34 and CD45). The cells maintained the ability to proliferate and differentiate into cells of mesenchymal lineages. The BMAs from the human calcaneal body offer a healthy source of multipotent MSCs.
Copyright © 2016 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  foot and ankle surgery; orthobiologic materials; osteoconduction; osteoinduction; surface markers

Mesh:

Year:  2017        PMID: 27989346      PMCID: PMC5171217          DOI: 10.1053/j.jfas.2016.09.006

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  24 in total

1.  Local bone graft harvested from the distal tibia or calcaneus for surgery of the foot and ankle.

Authors:  Steven M Raikin; Kenneth Brislin
Journal:  Foot Ankle Int       Date:  2005-06       Impact factor: 2.827

Review 2.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

3.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 4.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

5.  Comparison of mesenchymal stem cells (osteoprogenitors) harvested from proximal humerus and distal femur during arthroscopic surgery.

Authors:  Knut Beitzel; Mary Beth R McCarthy; Mark P Cote; Thomas J S Durant; David M Chowaniec; Olga Solovyova; Ryan P Russell; Robert A Arciero; Augustus D Mazzocca
Journal:  Arthroscopy       Date:  2013-01-03       Impact factor: 4.772

6.  Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors.

Authors:  G F Muschler; H Nitto; C A Boehm; K A Easley
Journal:  J Orthop Res       Date:  2001-01       Impact factor: 3.494

7.  Mesenchymal stem cell allograft in revision foot and ankle surgery: a clinical and radiographic analysis.

Authors:  Shannon M Rush; Graham A Hamilton; Lynn M Ackerson
Journal:  J Foot Ankle Surg       Date:  2009 Mar-Apr       Impact factor: 1.286

8.  Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects.

Authors:  Marcus Jäger; Monika Herten; Ulrike Fochtmann; Johannes Fischer; Philippe Hernigou; Christoph Zilkens; Christian Hendrich; Rüdiger Krauspe
Journal:  J Orthop Res       Date:  2010-08-25       Impact factor: 3.494

9.  Complications associated with autogenous bone marrow aspirate harvest from the lower extremity: an observational cohort study.

Authors:  Thomas S Roukis; Christopher F Hyer; Terrance M Philbin; Gregory C Berlet; Thomas H Lee
Journal:  J Foot Ankle Surg       Date:  2009-08-26       Impact factor: 1.286

10.  The role of a composite, demineralized bone matrix and bone marrow in the treatment of osseous defects.

Authors:  J J Tiedeman; K L Garvin; T A Kile; J F Connolly
Journal:  Orthopedics       Date:  1995-12       Impact factor: 1.390

View more
  4 in total

1.  Bone Marrow Aspirate Concentrate for the Treatment of Avascular Meniscus Tears in a One-Step Procedure-Evaluation of an In Vivo Model.

Authors:  Matthias Koch; Selma Hammer; Julian Fuellerer; Siegmund Lang; Christian G Pfeifer; Girish Pattappa; Johannes Weber; Markus Loibl; Michael Nerlich; Peter Angele; Johannes Zellner
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

2.  Multipotential stromal cells in the talus and distal tibia in ankle osteoarthritis - Presence, potency and relationships to subchondral bone changes.

Authors:  William G Jones; Jehan J El-Jawhari; C L Brockett; Lekha Koria; Ioannis Ktistakis; Elena Jones
Journal:  J Cell Mol Med       Date:  2020-12-11       Impact factor: 5.310

Review 3.  Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate.

Authors:  Madhan Jeyaraman; Shiva Kumar Bingi; Sathish Muthu; Naveen Jeyaraman; Rathinavelpandian Perunchezhian Packkyarathinam; Rajni Ranjan; Shilpa Sharma; Saurabh Kumar Jha; Manish Khanna; Sree Naga Sowndary Rajendran; Ramya Lakshmi Rajendran; Prakash Gangadaran
Journal:  Bioengineering (Basel)       Date:  2022-01-29

Review 4.  Adipose-PAS interactions in the context of its localised bio-engineering potential (Review).

Authors:  Michal Nohawica; Abdelmounaim Errachid; Marzena Wyganowska-Swiatkowska
Journal:  Biomed Rep       Date:  2021-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.